Inclusion in SRI Indices
Mitsubishi Tanabe Pharma's initiatives in the area of CSR activities have been highly evaluated, and we have been included in the following SRI Indices.*
- *Indicators of socially responsible investment, which utilizes evaluation/selection standards that consider not only corporate financial matters but also social responsibility.
Dow Jones Sustainability Indices (DJSI)
The DJSI are socially responsible investment indices developed by Dow Jones and RobecoSAM. Corporate sustainability is evaluated each year based on economic, environmental, and social factors, and companies with superior overall performance are selected as component companies. In September 2019, Mitsubishi Tanabe Pharma was selected for two consecutive years for DJSI Asia Pacific, the Asia Pacific subset of the DJSI.
FTSE4Good Index Series
Companies that meet global standards for Environmental, Social, and Governance (ESG) practices are selected as the components of this index, which was created by FTSE Russell. Mitsubishi Tanabe Pharma has been selected for 16 consecutive years since 2004. (June 2019)
FTSE Blossom Japan Index
From among the FTSE4Good component companies, Japanese companies that meet clear, highly transparent standards for Environmental, Social, and Governance (ESG) practices are selected as component companies for the FTSE Blossom Japan Index. Mitsubishi Tanabe Pharma has been selected for 3 consecutive years since 2017. (June 2019)
MSCI Japan Empowering Women Index (WIN)
From among the component companies of the MSCI Japan IMI Top 500 Index (top 500 companies by market capitalization), companies that are leaders in gender diversity in their sector groups are selected as the component companies for this index. (June 2019)
- *THE INCLUSION OF Mitsubishi Tanabe Pharma Corporation IN ANY MSCI INDEX, AND THE USE OF MSCI LOGOS, TRADEMARKS, SERVICE MARKS OR INDEX NAMES HEREIN, DO NOT CONSTITUTE A SPONSORSHIP, ENDORSEMENT OR PROMOTION OF Mitsubishi Tanabe Pharma Corporation BY MSCI OR ANY OF ITS AFFILIATES.
THE MSCI INDEXES ARE THE EXCLUSIVE PROPERTY OF MSCI. MSCI AND THE MSCI INDEX NAMES AND LOGOS ARE TRADEMARKS OR SERVICE MARKS OF MSCI OR ITS AFFILIATES.
SNAM Sustainability Index
This index is prepared by Sompo Japan Nipponkoa Asset Management Co., Ltd. Based on an original evaluation system, companies that exceed a standard score are selected as component companies for this index.
External CSR Evaluations
Won Special Encouragement Award at the "Ikumen Enterprise Award 2018,
in the Work-Life Balance Support Category"
As part of the Ministry of Health, Labour and Welfare's Ikumen Project that supports men's active participation in child-rearing and promotes their taking of childcare leave, the award commends companies and individuals who serve as models that promote a working environment conducive to giving birth and raising children with peace of mind while continuing to work. The Company won the Special Encouragement Award in the Work-Life Balance Support Category.
Acquisition of accreditation mark based on the Act on Advancement of Measures
to Support Raising Next-Generation Children
The Act on Advancement of Measures to Support Raising Next-Generation Children came into effect in 2005. In accordance with this law, companies that formulate action plans to support child-rearing by employees, achieve planned targets, and meet certain standards are eligible for certification by the Minister of Health, Labour and Welfare. The Company has been certified for six consecutive years since 2007. Among companies that had already been "Kurumin" certified, Mitsubishi Tanabe Pharma was "Platinum Kurumin" certified in July 2019.
Acquisition of "Eruboshi" certification mark
In accordance with the Act on Promotion of Women's Participation and Advancement in the Workplace, which came into effect in 2016, companies that formulate action plans to promote active careers for female employees and achieve excellent results with related initiatives are eligible for certification by the Minister of Health, Labour and Welfare. The Eruboshi mark demonstrates that a company has received this certification. In 2016, we received "Eruboshi," the highest level of certification, which is based on the Act on Promotion of Women's Participation and Advancement in the Workplace.
Selected as "Outstanding Enterprise in Health and Productivity Management ‐ White 500"
The "Outstanding Enterprise in Health and Productivity Management Certification System," which was established by the Ministry of Economy, Trade and Industry (METI) in 2016, is a system for recognizing companies and groups that are implementing especially strong health and productivity management. Of these companies, the White 500 program certifies large corporations that implement excellent health and productivity management in cooperation with their health insurance providers. This program, which is offered jointly by METI and Nippon Kenko Kaigi, is intended to expand the number of companies that are implementing health and productivity management. The program will certify 500 companies by 2020. Mitsubishi Tanabe Pharma has been selected for three consecutive years since 2017.
Acquisition of Certification as a Leading Company in the Support of Active Careers for Women
Each year, in accordance with established standards, Osaka City certifies companies and groups that are actively striving to establish environments that support active careers for women. Mitsubishi Tanabe Pharma received this certification in 2016.
Receipt of Award of Excellence at the 3rd Working Women Empowerment Awards
The Japan Productivity Center implements this wide-ranging award program for organizations that are conducting original, innovative initiatives with the aim of empowering women and increasing productivity. In June 2018, we received an award of excellence.
Awarded the SILVER Prize in the PRIDE INDEX for LGBT Issues
The PRIDE INDEX, established by "work with Pride," a private organization, is Japan's first index that evaluates the initiatives of companies and organizations related to sexual minorities such as LGBTs. MTPC was awarded the SILVER Prize in the PRIDE INDEX 2018.
Receipt of Excellence Award in the Environmental Report Section
of the 22nd Environmental Communication Awards
The purpose of the Environmental Communication Awards is to promote initiatives by companies and other organizations in the fields of environmental management and environmental communications and to enhance the quality of environmental information disclosure by recognizing excellent environmental reports and environmental activity reports. This award program is jointly sponsored by the Ministry of the Environment and the Global Environmental Forum. The Mitsubishi Tanabe Pharma Corporate Report 2018 and the CSR Activities Report 2018 received the Excellence Award in the Environmental Report Section. Following the previous year, Mitsubishi Tanabe Pharma's reports were selected for the second consecutive year.
Receipt of Award at Yokohama Global Warming Countermeasures Awards
In accordance with city regulations, under the Yokohama City global warming countermeasure plan, the city awards companies that have implemented superior initiatives to control greenhouse gas emissions. In fiscal 2017, for the second consecutive year, the Yokohama Site received the award for achieving a nearly 12% total reduction in CO2 emissions of approximately 710t-CO2 from fiscal 2011 to 2016 by consistently implementing priority measures called for by Yokohama City's global warming countermeasure plan, and taking energy-saving measures.